BiomX shareholders approve Dr. Frucht issuance, reverse split, auditor ratification

BiomX Inc.

Approved issuance of shares to Mandragola Ltd. for Dr. Frucht Systems acquisition: 9,313,228 for, 429,645 against.
Approved reverse stock split of 1-for-5 to 1-for-20; authorized shares cut from 750M to 150M.
Ratified Barzily & Co. as independent auditor for FY2026: 9,575,900 for.
Quorum reached with 9,813,430 shares (36.9% of 26,559,607 outstanding); adjournment not needed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.